Market Access News | pharmaphorum

News

UK study finds adults with ADHD have a big shortfall in life expectancy, raising questions about diagnosis rates and treatment access.

News

Johnson & Johnson's Spravato has become the first standalone drug to be cleared by the FDA for adults with treatment-resistant depression.

News

President Trump has started dismantling health legislation introduced under the Biden administration on day one of his new term.

News

Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.

News

Sanofi's consumer healthcare unit Opella could finally be able to bring an OTC PDE-5 inhibitor for erectile dysfunction to the US market.

News

One of the first acts of President Donald Trump after his inauguration yesterday was to order the start of the US's withdrawal from the WHO.